2019 International Congress » Non-Pharmacological Interventions

Date: Wednesday, September 25, 2019

Time: 1:15pm-2:45pm

Location: Les Muses Terrace, Level 3

Meeting: 2019 International Congress

1:15pm-2:45pm: “Poised for Parkinson’s”: Group classes in Alexander technique for managing symptoms of Parkinson’s disease

M. Gross, R. Ravichandra, M. Norcia, R. Cohen (Moscow, ID, USA)

1:15pm-2:45pm: A Large-Scale Survey of Rock Steady Boxing (RSB) Utilization in Parkinson’s Disease

D. Bega, D. Larson, M. Rafferty (Chicago, IL, USA)

1:15pm-2:45pm: Art du Deplacement (ADD)/Parkour therapy for people with Parkinson’s disease (PDP)

M. Schwed, T. Getrost, K. Torchia, G. Yao (Pfungstadt, Germany)

1:15pm-2:45pm: BeatPark: a new wearable device for gait auto-rehabilitation in Parkinson’s disease delivering adapted musical stimulation.

V. Cochen Decock, D. Dotov, L. Damm, MC. Picot, P. Ihalainen, V. Driss, C. Geny, B. Bardy, S. Dalla Bella (Montpellier, France)

1:15pm-2:45pm: Blue light therapy glasses in Parkinson’s disease: patients’ experience and effectiveness

K. Smilowska, D. van Wamelen, A. Schoutens, M. Meinders, B. Bloem (Nijmegen, Netherlands)

1:15pm-2:45pm: Can Google Glass improve freezing of gait in parkinsonism? A pilot study

A. Lee, N. Hellmers, M. Vo, P. Popa, C. Henchcliffe, H. Sarva, C. Campbell (New York, NY, USA)

1:15pm-2:45pm: Comparison of Current DBS Platforms in the United States

L. Surillo, U. Yazdani, S. Chitnis (Dallas, TX, USA)

1:15pm-2:45pm: Compression Therapy: A Treatment of Rubral Tremor

D. Nacopoulos (Erie, PA, USA)

1:15pm-2:45pm: Controlling levodopa and deep brain stimulation induced dystonia with interleaving and fractionalized current steering

A. Mammis, E. Feinstein (Newark, NJ, USA)

1:15pm-2:45pm: DBS for PD in Albania

I. Zekja, R. Alimehmeti, F. Dashi, S. Grabova, M. Petrela, M. Rralacolli, J. Kruja (Tirana, Albania)

1:15pm-2:45pm: Deep brain stimulation-guided optogenetic rescue of parkinsonian symptoms

B. Degos, M. Vandecasteele, S. Valverde, C. Piette, G. Gangarossa, W. Derousseaux, A. Aristieta Arbelaiz, J. Touboul, L. Venance (Paris, France)

1:15pm-2:45pm: Design of the PERSPECTIVE study: PERsonalized SPEeCh Therapy for actIVE conversation

J. Maas, N. de Vries, B. Bloem, J. Kalf (Nijmegen, Netherlands)

1:15pm-2:45pm: Developing an innovative telephone support line for people with Parkinson’s Disease

F. Mancini, T. Carta, S. Thomas, F. Bona, E. Buijs, P. Nee, B. Bloem (Milan, Italy)

1:15pm-2:45pm: eCARE-PD, a digital health platform for patient empowerment and online health tracking: experiences with co-design

T. Mestre, S. Grosjean, L. Bonneville, D. Grimes, E. Bate, M. Lê (Ottawa, ON, Canada)

1:15pm-2:45pm: EEG guided neurofeedback boosts effects of motor cortex neuromodulation of rTMS in Parkinson´s Disease Patients

J. Romero, A. Arroyo, J. Andreo, M. Del Castillo, J. Serrano, E. Rocon, N. Malpica, E. Melero, E. Sanz, M. Gil, E. Rodriguez (Madrid, Spain)

1:15pm-2:45pm: Effect of deep brain stimulation on endothelial function and heart rate variability in Parkinson’s disease

JH. Yoon, DG. Park (Suwon, Republic of Korea)

1:15pm-2:45pm: Effect of neurofeedback facilitation of the gait and balance imagery-related SMA activation on gait function in PD

M. Mihiara, H. Otomune, Y. Kajiyama, H. Fujimoto, N. Hattori, I. Miyai, K. Hanayama, Y. Sunada, H. Mochizuki (Kurashiki, Japan)

1:15pm-2:45pm: Effect of Subthalamic Deep Brain Stimulation (DBS) on Impulsive Control Disorders (ICD) and Dopamine Dysregulation Syndrome (DDS) – A Randomized Controlled Trial Evaluating Deep Brain Stimulation Using a New Multiple Source, Constant-Current Rechargeable System for Management of Symptoms of Parkinson’s Disease (INTREPID)

M. Okun, R. Jain, L. Chen, I. Study Group, A. Tröster (Gainesville, FL, USA)

1:15pm-2:45pm: Effects of dance and walking program on spatiotemporal gait parameters in Parkinson’s disease

A. Nogueira Haas, M. Santos Delabary, R. Gimenes Donida, M. Wolffenbuttel, E. Passos Monteiro, L. Peyré-Tartaruga (Porto Alegre, Brazil)

1:15pm-2:45pm: Effects of exergaming on attentional deficits and dual-tasking in Parkinson’s disease

E. Schaeffer, J. Busch, B. Roeben, S. Otterbein, P. Saraykin, E. Leks, I. Liepelt-Scarfone, M. Synofzik, M. Elshehabi, W. Maetzler, C. Hansen, S. Andris, D. Berg (66041, Germany)

1:15pm-2:45pm: Effects of Handwriting Exercise on Functional Outcome in Parkinson’s Disease: A Randomized Controlled Trial

N. Vorasoot, P. Termsarasab, K. Thadanipon, T. Pulkes (Bangkok, Thailand)

1:15pm-2:45pm: Effects of multi-professional education program for management of Parkinson’s disease alterations on quality of life of people who are living with disease: a randomized clinical trial

C. Dias, A. Costa, E. Okamoto, A. Sartori, C. Silva, M. Piemonte (São Paulo, Brazil)

1:15pm-2:45pm: Effects of three different physical therapies in body composition of Parkinson’s disease

AOF. Fagundes, EPM. Monteiro, MSD. Delabary, APZ. Zanardi, MZC. Casal, VFM. Martins, MW. Wolffenbuttel, ANH. Haas, FGM. Martinez, LPT. Tartaruga (Porto Alegre, Brazil)

1:15pm-2:45pm: Global implementation of efficacious voice treatment for Parkinson’s disease: LSVT LOUD in Germany, France and Japan

L. Ramig, T. Brauer, C. Airiau, M. Fujiu-Kurachi (Boulder, CO, USA)

1:15pm-2:45pm: Impact of Nordik Walking training in patients with Progressive Supranuclear Palsy

R. Kandel, B. Bhattarai (Lalitpur, Nepal)

1:15pm-2:45pm: Intensity-based exercise groupings in Parkinson’s Disease: Analysis from the Parkinson’s Foundation Quality Improvement Initiative (PF-QII)

D. Larson, A. Margolius, G. Hanzhi, S. Wu, A. Angela, M. Miriam, T. Simuni (Gainseville, FL, USA)

1:15pm-2:45pm: Interactive dual task exercises delivered via smart speaker: a feasibility study

J. Dean, J. Domingos (Aurora, CO, USA)

1:15pm-2:45pm: Kick Out PD: Mobility, Quality of Life, and Feasibility Outcomes in a Pilot Study of a PD-Specific Karate Intervention

B. Sennott, C. Niemet, M. Lee, C. Whitelock, M. Sanghvi, Y. Liu, J. Chodosh, D. Hall, C. Comella, J. Fleisher (Chicago, IL, USA)

1:15pm-2:45pm: KICK OUT PD: Qualitative Analysis of Expectations and Outcomes in a Pilot Study of a Parkinson’s Disease Karate Intervention

J. Fleisher, C. Niemet, B. Sennott, M. Lee, C. Whitelock, M. Sanghvi, J. Chodosh, D. Hall, C. Comella (New York, NY, USA)

1:15pm-2:45pm: Mindfulness Based Stress Reduction in People with Parkinson’s Disease and their Carepartners

D. Shah, S. Mantri, J. Cooney, A. Allen, K. Durham, J. Brantley, R. Vereen, P. Hickey, B. Scott (Durham, NC, USA)

1:15pm-2:45pm: Musicoterapy and Neurorehabilitation in Patients with Parkinson’s Disease

TR. Alcântara-Silva, DJS. Silva, AL. Alcântara-Silva, S. Suzuki-Godoy (Goiânia, Brazil)

1:15pm-2:45pm: Non-Invasive Vagus Nerve Stimulation: A non-pharmacological approach to target gait impairment in Parkinson’s disease?

A. Yarnall, R. Morris, H. Hunter, JP. Taylor, M. Baker, L. Rochester (Newcastle Upon Tyne, United Kingdom)

1:15pm-2:45pm: Outcomes of a Prospective, Multicenter, International Registry of Deep Brain Stimulation for Parkinson’s Disease

J. Vesper, R. Jain, A. Wang, H. Scholtes, V. Study Group, G. Deuschl (Düsseldorf, Germany)

1:15pm-2:45pm: Outcomes of Percutaneous Endoscopic Gastrostomy (PEG) Feeding in Parkinson’s

L. Brown, M. Oswal, H. Martin, A. Lindahl, R. Skelly (Derby, United Kingdom)

1:15pm-2:45pm: Park-Ease Trial: A Randomized Controlled Trial to Study the Efficacy of Exercises in Early-Stage Parkinson’s Disease

R. Swarnakar, S. Wadhwa, S. V, V. Goyal, V. Sreenivas (New Delhi, India)

1:15pm-2:45pm: Protective effect of anodal transcranial direct current stimulation on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice via modulating mitochondrial dynamics

W. Jang, JY. Ahn (Gangneung, Republic of Korea)

1:15pm-2:45pm: Provider Communication About Exercise in Parkinson’s Disease Before and After DBS surgery: A Retrospective Chart Review

I. Dustin, D. Ehrlich (Bethesda, MD, USA)

1:15pm-2:45pm: Randomized controlled trial of 1Hz SMA rTMS + gait training for Freezing of Gait

G. Revuelta, D. Lench, C. Hanlon, A. Hydar, W. Devries, S. Kautz (Charleston, SC, USA)

1:15pm-2:45pm: Real World Clinical Outcomes Using a Novel Directional Lead from a Multicenter Registry of Deep Brain Stimulation for Parkinson’s Disease

J. Vesper, R. Jain, A. Wang, H. Scholtes, V. Study Group, G. Deuschl (Düsseldorf, Germany)

1:15pm-2:45pm: Singing – tune into self-regulation: A holistic system perspective

E. Wünnenberg, M. Jungen (Frankfurt Am Main, Germany)

1:15pm-2:45pm: Single Centre Experience of PEG Feeding in Parkinson’s Disease

H. Fairclough, H. Bashir, R. Beekman, M. Lee, E. Johns, C. Mcdonald (Gateshead, United Kingdom)

1:15pm-2:45pm: Smartphone Applications Are Promising Modalities for Monitoring Parkinson’s Disease (PD) Symptoms

M. Qazi, H. Ellsworth, J. Chou, F. Wang, N. Hellmers, C. Henchcliffe, H. Sarva (Ny, NY, USA)

1:15pm-2:45pm: The efficiency of group cognitive rehabilitation to patients with Parkinson’s disease in comparison to relaxation therapy: pilot data

V. Plzáková, D. Enström, T. Nikolai (Prague, Czech Republic)

1:15pm-2:45pm: Transcranial Photobiomodulation as an adjunct to Levodopa therapy in patients with Parkinson’s Disease; an open label pilot study

H. Singh, N. Sawal (Chandigarh, India)

1:15pm-2:45pm: Transcriptome modification of anodal transcranial direct current stimulation in transgenic Parkinson’s disease mouse model

W. Jang, H-T. Kim (Seoul, Republic of Korea)

1:15pm-2:45pm: Virtual Reality EEG guided motor neurofeedback training has mid-term effects in Parkinson’s Disease Patients limits of stability

JP. Romero, A. Arroyo, J. Andreo, M. Del Castillo, J. Serrano, E. Rocon, N. Malpica, E. Melero, M. Gil, E. Sanz, P. Serrano, E. Rodriguez (Madrid, Spain)

« View all sessions from the 2019 International Congress.